The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals. The treatment is expected to be a breakthrough by aiding weight reduction, which in turn improves breathing during sleep.
Weight loss drug gets US nod to treat sleep apnea; India launch likely next year
Categories:
Related Post
US tightens business, tourism visa renewal rules, wait to get longerUS tightens business, tourism visa renewal rules, wait to get longer
Indian travelers renewing their American B1/B2 visas now face longer wait times as the US reinstates its pre-Covid policy. With wait times still over 400 days in major cities, the
‘No point in saying such baseless things’: Chirag on Tejashwi’s SOS for Nishant‘No point in saying such baseless things’: Chirag on Tejashwi’s SOS for Nishant
Union minister Chirag Paswan criticised Tejashwi Yadav for suggesting Nishant Kumar’s entry into politics, noting the decision is personal for Nishant. Tejashwi expressed concerns about the BJP’s influence on JD(U)
Watch: Babar clicks selfies with fans as Pakistan reach AustraliaWatch: Babar clicks selfies with fans as Pakistan reach Australia
Pakistan cricket is experiencing turbulence with coaching changes and leadership shifts before important tours. Former captain Babar Azam arrived in Australia and was warmly welcomed by fans. He will play